- Home
- / Quadrant Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Quadrant Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$10 M
Revenue
$36.4 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 11.8M | 60.5M | 36.4M |
| Cost of goods sold | 8.6M | 33.5M | 14.3M |
| Gross profit | 3.2M | 27.1M | 22.1M |
| Gross profit margin, % | 27.0% | 44.7% | 60.6% |
| General and administrative expense | 6.6M | 10.0M | 22.2M |
| Operating expense total | 7.7M | 10.4M | 24.9M |
| EBIT | (4.5M) | 16.7M | (2.9M) |
| EBIT margin, % | -38.0% | 27.5% | -7.9% |
| Interest income | 1.9K | ||
| Interest expense | 291.5K | 309.8K | 325.3K |
| Pre tax profit | (4.1M) | 16.6M | (2.7M) |
| Income tax expense | (5.8M) | 4.4M | (206.4K) |
| Net Income | 1.7M | 12.2M | (2.4M) |
| EPS | 0.0 | 0.1 | 0.0 |